A rapid enzyme immunoassay (EIA) for cocaine and its main metabolite, benzoylecgonine (BZE), using glucose oxidase (GOD) was established. Drug concentrations in samples were determined by the inhibition test. BZE-conjugated GOD and samples were added into the wells of a 96-well microtest plate coated with anti-BZE monoclonal antibody. After washings, color development was performed by additions of glucose, horse radish peroxidase (HRP) and 3,3′,5,5′-tetramethylbenzidine (TMB), which was a non-mutagenic and non-carcinogenic chromogen. The time required for the immune reaction and the subsequent color development was only 12 min in this EIA. The EIA specifically detected cocaine and BZE at the low detection limit, that is, about 45.4 pg/well for cocaine, and 433 pg/well for BZE, respectively. The values were hardly interfered by urine diluted to 10%. The present assay method was rapid, sensitive, simple, and safe, and was easily carried out anyplace a micro-plate reader was available. Therefore, it might be suitable to screen cocaine and BZE in urine at the scene of abuse.
INTRODUCTION
The illegal use of narcotics and stimulants has been increasing around the world. To deal with such drug abuse, rapid and precise analyses are required. Enzyme immunoassays (EIA) are suitable for providing such screens, since biological samples are directly measured without extraction and concentration. Use of EIA for screening drugs requires labeling enzymes and color development systems. In recent years, various EIAs for various drugs have been developed. A variety of enzymes such as alkaline phosphatase, horseradish peroxidase (HRP) and β-galactosidase, glucose oxidase (GOD), have been used as labels in EIA. 1) In the present study, we intended to establish a rapid and easily manipulated EIA for screening cocaine and its main metabolite, benzoylecgonine (BZE), in urine. We chose GOD as a label enzyme because it gives excellent results in combination with free HRP, 2) and there is little work with GOD in the field of drug abuse testing. GOD produces hydrogen peroxide by catalyzing the oxidation of β-D-glucose to D-glucono-δ-lactone in the presence of molecular oxygen. The amount of hydrogen peroxide produced can be detected by a colorimetric method in combination with peroxidase and its substrates (chromogens) such as o-phenylenediamine (OPD), 2,2′-azino-bis(3-ethybenz-thiazoline-6-sulfonic acid (ABTS) and 3,3′,5,5′-tetramethylbenzidine (TMB). It has been reported that ABTS and OPD are mutagenic and carcinogenic, 3) but TMB is neither mutagenic 4) nor carcinogenic, 5) and TMB is more sensitive than OPD and ABTS in combination with HRP and hydrogen peroxide. 6) However, TMB has the weak point of being labile in aqueous buffers. Very recently, a stabilization method of TMB solution using tetrabutyl ammoniumborohydride has been established. 7) The principle of the present EIA is that the amount of BZE or cocaine in samples is determined by competitive inhibition with BZE-conjugated GOD to anti-BZE-monoclonal antibody coated on a plate. TMB was then used as a chromogen for color development.
MATERIALS AND METHODS
Regents ---GOD derived from Asp. niger (Lot No. SEL7705) 8) and TMB were purchased from Wako Pure Chemical Industries (Osaka, Japan). Cocaine hydrochloride and codeine phosphate were purchased from Takeda Chemical Industries, Ltd. (Osaka, Japan). Anti-BZE monoclonal antibody was from Biogenesis Co. (England, U.K.). Ecgonine, *To whom correspondence should be addressed: Department of Hygienic Chemistry, Showa Pharmaceutical University, 3-3165 Higashitamagawagakuen, Machida, Tokyo 194-8543, Japan. Tel.: +81-42-721-1564; Fax: +81-42-721-1563; E-mail: hojo@ ac.shoyaku.ac.jp 419-423 (2001) ecgonine methylester, ethylmorphine, dihydrocodeine, oxymethebanol, pethidine, fentanyl, methamphetamine, and amphetamine were supplied from the custody of the Kanto-Shin'etsu Regional Narcotic Control Office, Ministry of Health and Welfare. BZE was synthesized from cocaine in our laboratory. 9) A micro-test plate with 96 wells (F96 Maxsorp Nunc-Immunoplate) was purchased from Nunc (Denmark). Preparation of BZE-Conjugated GOD (BZE-GOD) ---BZE was coupled to GOD according to the modified Wainer's method. 10, 11) Briefly, a mixture of 100 mg of BZE, 45 µl of isobutylchloroformate and 8.2 µl of tributylamine was dissolved in 1 ml of dimethylformamide and stirred at 4°C for 30 min, and then supplied with 1 ml of water (solution A). GOD solution (128 mg/ml water) was mixed with 1 ml of dimethylformamide and incubated at 4°C for 30 min at pH 8.5 (solution B). Then, both solution A and B were reacted at pH 8.5 at 4°C for 4 hr, and dialyzed against water for 3 days and lyophilized. EIA ---Wells of the micro-test plate were coated with 100 µl of anti-BZE antibody (1 µg/ml of 0.05 M carbonate-bicarbonate buffer, pH 9.6) at 4°C overnight, blocked with 0.5% skimmed milk in 0.05% Tween 20-PBS (T-PBS) and washed twice with T-PBS. For drawing a standard inhibition curve, 50 µl of BZE-GOD (5 µg/ml) and 50 µl of several concentrations of cocaine or BZE were added into the antibody-coated plate and reacted for 15 min at room temperature. After triple washings, a mixture (100 µl) of glucose (1 mg), HRP (5 ng) and TMB (20 nmol) was added into the wells and incubated at room temperature for several minutes. The reaction was stopped by the addition of 50 µl of 1 M sulfuric acid, and the absorbance at 450 nm was measured by a micro-plate reader (Model 3550, Biorad, CA, U.S.A.).
RESULTS AND DISCUSSION
The purpose of this work was to construct a rapid, sensitive and handy EIA for screening cocaine and BZE. The optimal assay conditions for this EIA were first examined. Then, competitive inhibitions by various drugs were evaluated.
Optimal Assay Conditions for EIA
We selected GOD as an enzyme label. First, the amount of BZE-GOD binding to anti-BZE monoclonal antibody coated on a 96-well microtest plate was examined. The binding of BZE-GOD with the antibody was dose-dependently increased and almost maximal at 3 µg/ml when incubated for 15 min (Fig. 1A) , and approximate equilibrium was achieved in 6 min when 2.5 µg/ml of BZE-GOD was used (Fig. 1B) .
Second, the conditions for color development were examined. In order to measure hydrogen peroxide produced by GOD from glucose, the combination of HRP and TMB, which was one of the most sensitive enzymatic detection systems, 6) was applied in this EIA. In the case of the EIA in which HRP was used as a label, a substrate solution of diluted hydrogen peroxide had to be prepared from a bit of toxic and dangerous hydrogen peroxide stock solution (e.g. 30% v/v) immediately prior to use. Therefore, the use of HRP as a label is not reasonable. When 2.5 µg/ml of BZE-GOD was incubated with anti-BZE antibody for 15 min, color was maximally developed in the range of 50-100 ng/ml of HRP ( Fig. 2A) and increased in a time-dependent manner in the first 6 min (Fig. 2B) . It took 12 min at a minimum for both the binding between BZE-GOD and anti-BZE antibody and the color development in the EIA. TMB is a non-mutagenic and non-carcinogenic chromogen. 4, 5, 12) The safety of reagents is the most important prerequisite for assays used anyplace other than the laboratory.
Competitive Inhibition by Various Drugs of the Binding between BZE-GOD and Anti-BZE Antibody
The competitive inhibition by cocaine or BZE of the binding between BZE-GOD and anti-BZE antibody is shown in Fig. 3 . The measurable doses were in the range of 3-400 nM (45.5-6060 pg/well) for cocaine and 30-1000 nM (433-14450 pg/well) for BZE, respectively. Table 1 shows the competitive inhibition by cocaine metabolites and some other drugs. The value of IC 50 was 15 nM for cocaine and that for BZE was 180 nM. The antibody used was raised against BZE as hapten, but it showed higher reactivity with cocaine than with BZE. Ecgonine methylester inhibited the binding at extremely higher concentrations (IC 50 : 3.1 mM) than cocaine or BZE did, but the other drugs did not show any inhibition at 1 mM. It was important that this EIA system specifically detected cocaine and BZE.
Assay methods based on immune reactions have advantages of being directly applicable to biological samples. However, they are often interfered with specifically or nonspecifically by biological components. We tested whether the present EIA was affected by normal urine. Binding of BZE-GOD with anti-BZE antibody coated on the plate was reduced less than 10% by the addition of 10% urine from five donors (Fig. 4A) . However, the calibration curve for BZE was hardly affected by the addition of the same concentration of urine (Fig. 4B) , even if glucose (10 mg/ ml) was added (data not shown). Therefore, the lowest detectable limit of BZE in urine is calculated as 4.33 ng/well (86.6 ng/ml of urine), if urine samples diluted to 10% are measured.
Cocaine or BZE might be quickly measured by the present method, if an antibody-coated plate has been prepared. This method is specific and sensitive for cocaine and BZE, and is easily and safely manipulated. Therefore, the present EIA might be useful for screening cocaine and BZE in specimens of cocaine abuse.
